Categories Earnings, Health Care
Earnings Summary: Everything you need to know about IDEXX’s Q4 2023 report
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a provider of pet healthcare innovation, on Monday reported higher revenues and net income for the fourth quarter of 2023.
- Fourth-quarter revenues increased 9% annually to $901.6 million; organic revenue growth was 8%
- Net income attributable to shareholders moved up to $194.52 million from $172.2 million a year earlier
- On a per-share basis, fourth-quarter earnings rose to $2.32 per share from $2.05 per share in Q4 2022
- For fiscal 2024, the management expects revenues to be in the range of $3.93 billion to $4.04 billion, reflecting a growth of 7.5-10.5%
- Full-year organic revenue growth is expected to be between 7% and 10%
- The management is looking for earnings of $10.84 per share to $11.33 per share for FY24, an increase of 8-13% as reported and on a comparable basis
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was
